Abstract
In order to investigate the biological role of fibronectin in glioma cell invasion, we studied the relation between migratory responses or adhesiveness of glioma cells to fibronectin and the in vitro invasion in three human malignant glioma cell lines, A172, T98G and U373MG. All these cell lines chemotactically migrated in a dose-dependent manner to fibronectin in concentrations ranging from 0.5 to 10 µg/ml, with A172 cells showing the strongest migration and U373 cells the weakest. Checkerboard analyses demonstrated that A172 and T98G cells showed much stronger chemokinetic responses to fibronectin than U373MG cells. In contrast to the migratory responses, A172 and U373MG cells showed an almost equally high adhesion to fibronectin and T98G cells a low adhesion. The degree of expression of the integrin α5 subunit correlated well with the strength of glioma cell adhesion to fibronectin rather than that of migration to the molecule. Furthermore, the cell adhesion to fibronectin was almost completely inhibited by arginine-glycine-aspartic acid (RGD)-containing peptides, but the fibronectin-stimulated cell migration was only partially inhibited. An in vitro invasion assay disclosed that U373MG cells invaded the artificial basement membrane barrier the most and A172 cells the least. However, addition of fibronectin to the glioma cells markedly enhanced the invasive activity of A172 and T98G cells but had little effect on that of U373MG cells. These results indicate that fibronectin-stimulated migration can be one of the factors promoting invasiveness of glioma cells and that the chemokinetic activity of fibronectin may play a crucial role in glioma invasion through conferring motor-driving force on the glioma cells.
Similar content being viewed by others
References
Gabbert H, 1985, Mechanisms of tumor invasion: evidence from in vivoobservations. Cancer Metast Rev, 4, 293–309.
Mareel MM and De Mets M, 1984, Effect of microtubule inhibitors on invasion and on related activities of tumor cells. Int Rev Cytol, 90, 125–68.
Strauli P and Haemmerli G, 1984, Cancer cell locomotion. In: Mareel MM and Calman KC, eds. I nvasion. Experimental and Clinical Implications. Oxford: Oxford University Press, pp. 252–74.
Ambrose EJ and Easty DM, 1976, Time-lapse filming of cellular interactions within living tissues. III. The role of cell shape. Differentiation, 6, 61–70.
Haemmerli G, Arnold B and Strauli P, 1982, Cell locomotion, a contributing factor in spread of the V2 rabbit carcinoma. Int J Cancer, 29, 223–7.
Yamaura H, Suzuki M and Sato H, 1971, Transparent chamber in the rat skin for studies on microcirculation in cancer tissue. Gann, 62, 177–85.
Locker J, Goldblatt PJ and Leighton J, 1970, Ultrastructure features of invasion in chick embryo liver metastasis of Yoshida ascites hepatoma. Cancer Res, 30, 1632–44.
Mareel MM, 1980, Recent aspects of tumor invasiveness. In: Richter GW and Epstein MA, eds. International Review of Experimental Pathology,Vol. 22. New York: Academic Press, pp. 65–129.
Liotta LA, Mandler R, Murano G, et al. 1986, Tumor cell autocrine motility factor. Proc Natl Acad Sci, USA, 83, 3302–6.
Ohnishi T, Arita N, Hayakawa T, Izumoto S, Taki T and Yamamoto H, 1990, Motility factor produced by malignant glioma cells: role in tumor invasion. J Neurosurg, 73, 881–8.
Hayman EG, Pierschbacher MD, Suzuki S and Ruoslahti E, 1985, Vitronectin-a major cell attachment-promoting protein in fetal bovine serum. Exp Cell Res, 160, 245–58.
Terranova VP, Rohrbach DH and Martin GR, 1980, Role of laminin in the attachment of PAM 212 (epithelial) cells to basement membrane collagen. Cell, 22, 719–26.
Tsukamoto Y, Helsel WE and Wahl SM, 1981, Macrophage production of fibronectin, a chemoattractant for fibroblasts. J Immunol, 127, 673–8.
Bronner-Fraser M, 1986, An antibody to a receptor for fibronectin and laminin perturbs cranial neural crest development. Dev Biol, 117, 528–36.
Lacovara J, Cramer EB and Quigley JP, 1984, Fibronectin enhancement of directed migration of B16 melanoma cells. Cancer Res, 44, 1657–63.
Liotta LA, Rao CN and Wewer UM, 1986, Biochemical interactions of tumor cells with the basement membrane. Ann Rev Biochem, 55, 1037–57.
McCarthy JB and Furcht LT, 1984, Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro. J Cell Biol, 98, 1474–80.
Humphries MJ, Olden K and Yamada KM, 1986, A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science, 233, 467–70.
Gehlsen KR, Argraves WS, Pierschbacher MD and Ruoslahti E, 1988, Inhibition of in vitrotumor cell invasion by Arg-Gly-Asp-containing synthetic peptides. J Cell Biol, 106, 925–30.
Higuchi M, Ohnishi T, Arita N, et al. 1991, Immunohistochemical localization of fibronectin, laminin and fibronectin-receptor in human malignant gliomas-in relation to tumor invasion. Brain and Nerve (Tokyo), 43, 17–23.
Zigmond SH and Hirsch JG, 1973, Leukocyte locomotion and chemotaxis: new methods for evaluation and demonstration of a cell derived chemotactic factor. J Exp Med, 137, 387–410.
McCarthy JB, Palm SL and Furcht LT, 1983, Migration of haptotaxis of a Schwann cell tumor line to the basement membrane glycoprotein laminin. J Cell Biol, 97, 772–7.
Ohnishi T, Arita N, Hayakawa T, Kawahara K, Kato K and Kakinuma A, 1993, Purification of motility factor (GMF) from human malignant glioma cells and its biological significance in tumor invasion. Biochem Biophys Res Commun, 193, 518–25.
Carter SB, 1967, Haptotaxis and the mechanism of cell motility. Nature, 213, 256–60.
Hynes RO, 1987, Integrins: a family of cell surface receptors. Cell, 48, 549–54.
Hynes RO, 1992, Integrins: versatility, modulation, and signaling in cell adhesion. Cell, 69, 11–25.
Plantefaber LC and Hynes RO, 1989, Changes in integrin on oncogenically transformed cells. Cell, 56, 281–90.
Dedhar S and Saulnier R, 1990, Alterations in integrin receptor expression on chemically transformed human cells: specific enhancement of laminin and collagen receptor complexes. J Cell Biol, 110, 481–9.
Yamada KM and Olden K, 1978, Fibronectin-adhesive glycoproteins of cell surface and blood. Nature, 275, 179–84.
Pearlstein E, Gold LI and Garcia-Pardo A, 1980, Fibronectin: a review of its structure and biological activity. Mol Cell Biochem, 29, 103–28.
Couchman JR, Ress DA, Green MR and Smith CG, 1982, Fibronectin has a dual role in locomotion and anchorage of primary chick fibroblasts and can promote entry into the division cycle. J Cell Biol, 93, 402–10.
Yamada K, Ushio Y, Hayakawa T, Arita N, Yamada N and Mogami H, 1983, Effects of methylpredonisolone on peritumoral brain edema. A quantitative autoradiographic study. J Neurosurg, 59, 612–19.
Shapiro WR, Hiesiger EM, Cooney GA, Lipschutz LE, Basler GA and Posner JB, 1990, Temporal effects of dexamethasone on blood-to-brain and blood-totumor transport of 14C-alpha-aminoisobutyric acid in rat C6 glioma. J Neuro-Oncol, 8, dy197–204.
Jones TR, Ruoslahti E, Schold SC and Bigner DD, 1982, Fibronectin and glial fibrillary acidic protein expression in normal human brain and anaplastic human gliomas. Cancer Res, 42, 168–77.
Paetau A, Mellstrom K, Vaheri A and Haltia M, 1980, Distribution of a major connective tissue protein, fibronectin, in normal and neoplastic human nervous tissue. Acta Neuropathol, 51, 47–51.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohnishi, T., Arita, N., Hiraga, S. et al. Fibronectin-mediated cell migration promotes glioma cell invasion through chemokinetic activity. Clin Exp Metastasis 15, 538–546 (1997). https://doi.org/10.1023/A:1018422926361
Issue Date:
DOI: https://doi.org/10.1023/A:1018422926361